Community Health Systems, Inc. (CYH)
NYSE: CYH · Real-Time Price · USD
2.760
+0.030 (1.10%)
Oct 9, 2026, 4:00 PM EDT - Market closed
Community Health Systems Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 11,983 | 12,485 | 12,634 | 12,490 | 12,211 | 12,368 | |
Revenue Growth | -5.25% | -1.18% | 1.15% | 2.28% | -1.27% | 4.91% |
Cost of Revenue | 7,021 | 7,276 | 7,364 | 7,408 | 7,305 | 7,284 |
Gross Profit | 4,962 | 5,209 | 5,270 | 5,082 | 4,906 | 5,084 |
Selling, General & Admin | 267 | 277 | 299 | 319 | 317 | 308 |
Other Operating Expenses | 3,301 | 3,424 | 3,642 | 3,388 | 3,336 | 2,958 |
Operating Expenses | 4,005 | 4,127 | 4,427 | 4,212 | 4,187 | 3,806 |
Operating Income | 957 | 1,082 | 843 | 870 | 719 | 1,278 |
Interest Expense | -859 | -872 | -863 | -832 | -860 | -888 |
Interest & Investment Income | 2 | 2 | 3 | 2 | 2 | 3 |
Earnings From Equity Investments | 11 | 9 | 10 | 8 | 14 | 22 |
EBT Excluding Unusual Items | 111 | 221 | -7 | 48 | -125 | 415 |
Gain (Loss) on Sale of Investments | - | - | - | - | - | 39 |
Gain (Loss) on Sale of Assets | 496 | 387 | 4 | - | - | - |
Asset Writedown | -182 | -72 | -305 | 87 | -71 | -24 |
Other Unusual Items | 38 | 188 | 25 | 72 | 545 | 69 |
Pretax Income | 463 | 724 | -283 | 207 | 349 | 499 |
Income Tax Expense | 53 | 48 | 79 | 191 | 170 | 131 |
Earnings From Continuing Operations | 410 | 676 | -362 | 16 | 179 | 368 |
Net Income to Company | 410 | 676 | -362 | 16 | 179 | 368 |
Minority Interest in Earnings | -158 | -167 | -154 | -149 | -133 | -138 |
Net Income | 252 | 509 | -516 | -133 | 46 | 230 |
Net Income to Common | 252 | 509 | -516 | -133 | 46 | 230 |
Net Income Growth | - | - | - | - | -80.00% | -54.99% |
Shares Outstanding (Basic) | 134 | 134 | 132 | 130 | 129 | 127 |
Shares Outstanding (Diluted) | 136 | 135 | 132 | 130 | 130 | 131 |
Shares Change | 2.26% | 2.20% | 1.27% | 0.30% | -0.41% | 12.06% |
EPS (Basic) | 1.88 | 3.81 | -3.91 | -1.02 | 0.36 | 1.81 |
EPS (Diluted) | 1.85 | 3.77 | -3.91 | -1.02 | 0.35 | 1.76 |
EPS Growth | - | - | - | - | -80.11% | -59.91% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -185 | 208 | 120 | -257 | -115 | -600 |
Free Cash Flow Per Share | -1.36 | 1.54 | 0.91 | -1.97 | -0.88 | -4.59 |
Gross Margin | 41.41% | 41.72% | 41.71% | 40.69% | 40.18% | 41.11% |
Operating Margin | 7.99% | 8.67% | 6.67% | 6.97% | 5.89% | 10.33% |
Profit Margin | 2.10% | 4.08% | -4.08% | -1.06% | 0.38% | 1.86% |
Free Cash Flow Margin | -1.54% | 1.67% | 0.95% | -2.06% | -0.94% | -4.85% |
EBITDA | 1,332 | 1,446 | 1,249 | 1,295 | 1,168 | 1,710 |
EBITDA Margin | 11.12% | 11.58% | 9.89% | 10.37% | 9.56% | 13.83% |
D&A For EBITDA | 375 | 364 | 406 | 425 | 449 | 432 |
EBIT | 957 | 1,082 | 843 | 870 | 719 | 1,278 |
EBIT Margin | 7.99% | 8.67% | 6.67% | 6.97% | 5.89% | 10.33% |
Effective Tax Rate | 11.45% | 6.63% | - | 92.27% | 48.71% | 26.25% |